1. Apolipoprotein E ε4 is superior to apolipoprotein E ε2 in predicting cognitive scores over 30 months.
- Author
-
Regal P, Nair B, and Hetherington E
- Subjects
- Aged, Aged, 80 and over, Cognition Disorders genetics, Cohort Studies, Female, Genetic Markers, Humans, Male, Neuropsychological Tests, New South Wales, Predictive Value of Tests, Prospective Studies, Sex Distribution, Apolipoprotein E2 genetics, Apolipoprotein E4 genetics, Cognition Disorders diagnosis
- Abstract
Background: The purpose of this study was to compare apolipoprotein E ε4 (Apo E ε4) and apolipoprotein E ε2 (Apo E ε2) as predictors of cognitive and functional trajectories over 30 months., Methods: This prospective cohort study included 287 community-dwelling memory clinic patients with dementia, mild cognitive impairment, or no cognitive impairment. The Addenbrooke Cognitive Examination, Mini-Mental State Examination, Montreal Cognitive Assessment, Delirium Index, and Nottingham Instrumental Activities of Daily Living tests were administered to each subject., Results: One hundred and nine subjects (40%) carried Apo E ε4 and 48 (16.7%) carried Apo E ε2. One hundred and nine ε4-positive subjects differed significantly from 178 ε4-negative subjects in 19/52 comparisons (36.5%), whereas 46 Apo E ε2-positive subjects had 0/52 significant differences from 239 ε2-negative subjects (P < 0.0001). The variables most affected by ε4 were the Delirium Index and Mini-Mental State Examination. Instrumental Activities of Daily Living score and residence were unrelated to Apo E ε4 or ε2., Conclusion: Apo E ε4 positivity predicted four cognitive scores measured every 6 months over 30 months. Apo E ε2 scores predicted none of 52 comparisons.
- Published
- 2013
- Full Text
- View/download PDF